UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Factors associated with treatment type of non-malarial febrile illnesses in under-fives at Kenyatta National Hospital in Nairobi, Kenya

PloS one, 2019-06, Vol.14 (6), p.e0217980-e0217980

2019

Volltextzugriff (PDF)

Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya

PloS one, 2017-09, Vol.12 (9), p.e0183788-e0183788

2017

Volltextzugriff (PDF)

Hope amidst neglect: Mycetoma Research Center, University of Khartoum. A holistic management approach to achieve the United Nations' Sustainable Development Goals

PLoS neglected tropical diseases, 2024-09, Vol.18 (9), p.e0012420

2024

Volltextzugriff (PDF)

Epidemiological cut‐off values for itraconazole and ravuconazole for Madurella mycetomatis, the most common causative agent of mycetoma

Mycoses, 2022-12, Vol.65 (12), p.1170-1178

2022

Volltextzugriff (PDF)

Using (1,3)‐β‐D‐glucan concentrations in serum to monitor the response of azole therapy in patients with eumycetoma caused by Madurella mycetomatis

Mycoses, 2024-01, Vol.67 (1), p.e13664-n/a

2024

Volltextzugriff (PDF)

P4.17 Contraceptive preference among female sex workers in the sivet study in nairobi, kenya

Sexually transmitted infections, 2017-07, Vol.93 (Suppl 2), p.A198

Nyaoke, Borna

2017

Volltextzugriff (PDF)

Towards enhanced control of mycetoma: a roadmap to achieve the UN's sustainable development goals by 2030

Transactions of the Royal Society of Tropical Medicine and Hygiene, 2024-10, Vol.118 (10), p.646-651

2024

Volltextzugriff (PDF)

IV and oral fosfomycin pharmacokinetics in neonates with suspected clinical sepsis

Journal of antimicrobial chemotherapy, 2021-06, Vol.76 (7), p.1855-1864

2021

Volltextzugriff (PDF)

Patterns of antibiotic use, pathogens, and prediction of mortality in hospitalized neonates and young infants with sepsis: A global neonatal sepsis observational cohort study (NeoOBS)

PLoS medicine, 2023-06, Vol.20 (6), p.e1004179-e1004179

2023

Volltextzugriff (PDF)

S4.5c Using serum beta-glucan measurements and sequencing of the Madurella mycetomatis azole target gene to predict therapeutic outcome during azole treatment in human mycetoma

Medical mycology (Oxford), 2022-09, Vol.60 (Supplement_1)

2022

Volltextzugriff (PDF)

Randomised controlled trial of fosfomycin in neonatal sepsis: pharmacokinetics and safety in relation to sodium overload

Archives of disease in childhood, 2022-09, Vol.107 (9), p.802-810

2022

Volltextzugriff (PDF)

Simultaneous pharmacokinetic/pharmacodynamic (PKPD) assessment of ampicillin and gentamicin in the treatment of neonatal sepsis

Journal of antimicrobial chemotherapy, 2022-02, Vol.77 (2), p.448-456

2022

Volltextzugriff (PDF)

P445 Clinical evaluation of the performance of the most commonly used eumycetoma diagnostic tests using sequencing of the internally transcribed spacer region as the golden standard

Medical mycology (Oxford), 2022-09, Vol.60 (Supplement_1)

2022

Volltextzugriff (PDF)

S4.5d Comparing the diagnostic performance of the commonly used eumycetoma diagnostic tests using sequencing of the internally transcribed spacer region as the gold standard

Medical mycology (Oxford), 2022-09, Vol.60 (Supplement_1)

2022

Volltextzugriff (PDF)

S4.5b A randomized, double blind phase II proof-of-concept superiority trial of fosravuconazole 200 mg or 300 mg weekly dose versus itraconazole 400 mg daily, all three arms in combination with surgery, in patients with eumycetoma in Sudan—pharmacokinetic results

Medical mycology (Oxford), 2022-09, Vol.60 (Supplement_1)

2022

Volltextzugriff (PDF)

Comparing the performance of the common used eumycetoma diagnostic tests

Mycoses, 2023-05, Vol.66 (5), p.420-429

2023

Volltextzugriff (PDF)

Live Attenuated Zoster Vaccine Boosts Varicella Zoster Virus (VZV)-Specific Humoral Responses Systemically and at the Cervicovaginal Mucosa of Kenyan VZV-Seropositive Women

The Journal of infectious diseases, 2018-09, Vol.218 (8), p.1210-1218

2018

Volltextzugriff (PDF)

Live attenuated varicella-zoster virus vaccine does not induce HIV target cell activation

The Journal of clinical investigation, 2019-02, Vol.129 (2), p.875-886

2019

Volltextzugriff (PDF)

Motivators to Participate in aNon-HIV Experimental Study among HIV-Infected Individuals in Nairobi, Kenya: A ConsecutiveSample of an Ebola Vaccine Clinical Trial

Journal of Vaccines, Immunology and Immunopathology, 2017-11, Vol.3 (3)

2017

Volltextzugriff (PDF)

Analysis from the NeoOBS Global Neonatal Sepsis Prospective Observational Cohort Study Across 19 Hospitals in 11 Countries; Clinical Presentation, Treatment, Mortality Outcomes and Development of the NeoSEP Sepsis Severity Score

SSRN Electronic Journal

Volltextzugriff (PDF)

Clinical Presentation and 28-Day Mortality in Hospitalized Neonates and Young Infants with Clinical Sepsis: The Global NeoOBS Observational Cohort

SSRN Electronic Journal

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Thema

Science & Technology
(13)
Humans
(12)
Life Sciences & Biomedicine
(11)
Clinical Trials
(5)
Infections
(5)
Oral Presentations
(5)
Female
(4)
Infant
(4)
Infant, Newborn
(4)
Infectious Diseases
(4)
Medicine And Health Sciences
(4)
Microbiology
(4)
Mycetoma
(4)
Neonatal Sepsis - Drug Therapy
(4)
Patients
(4)
Adult
(3)
Analysis
(3)
Anti-Bacterial Agents - Therapeutic Use
(3)
Antimicrobial Agents
(3)
Biology And Life Sciences
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Factors associated with treatment type of non-malarial febrile illnesses in under-fives at Kenyatta National Hospital in Nairobi, Kenya

Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya

Hope amidst neglect: Mycetoma Research Center, University of Khartoum. A holistic management approach to achieve the United Nations' Sustainable Development Goals

Epidemiological cut‐off values for itraconazole and ravuconazole for Madurella mycetomatis, the most common causative agent of mycetoma

Using (1,3)‐β‐D‐glucan concentrations in serum to monitor the response of azole therapy in patients with eumycetoma caused by Madurella mycetomatis

P4.17 Contraceptive preference among female sex workers in the sivet study in nairobi, kenya

Towards enhanced control of mycetoma: a roadmap to achieve the UN's sustainable development goals by 2030

IV and oral fosfomycin pharmacokinetics in neonates with suspected clinical sepsis

Patterns of antibiotic use, pathogens, and prediction of mortality in hospitalized neonates and young infants with sepsis: A global neonatal sepsis observational cohort study (NeoOBS)

S4.5c Using serum beta-glucan measurements and sequencing of the Madurella mycetomatis azole target gene to predict therapeutic outcome during azole treatment in human mycetoma

Randomised controlled trial of fosfomycin in neonatal sepsis: pharmacokinetics and safety in relation to sodium overload

Simultaneous pharmacokinetic/pharmacodynamic (PKPD) assessment of ampicillin and gentamicin in the treatment of neonatal sepsis

P445 Clinical evaluation of the performance of the most commonly used eumycetoma diagnostic tests using sequencing of the internally transcribed spacer region as the golden standard

S4.5d Comparing the diagnostic performance of the commonly used eumycetoma diagnostic tests using sequencing of the internally transcribed spacer region as the gold standard

S4.5b A randomized, double blind phase II proof-of-concept superiority trial of fosravuconazole 200 mg or 300 mg weekly dose versus itraconazole 400 mg daily, all three arms in combination with surgery, in patients with eumycetoma in Sudan—pharmacokinetic results

Two dose levels of once-weekly fosravuconazole versus daily itraconazole in combination with surgery in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial

Comparing the performance of the common used eumycetoma diagnostic tests

S4.5a A randomized, double blind phase II proof-of-concept superiority trial of fosravuconazole 200 mg or 300 mg weekly dose versus itraconazole 400 mg daily, all three arms in combination with surgery, in patients with eumycetoma in Sudan—top line results

Live Attenuated Zoster Vaccine Boosts Varicella Zoster Virus (VZV)-Specific Humoral Responses Systemically and at the Cervicovaginal Mucosa of Kenyan VZV-Seropositive Women

Live attenuated varicella-zoster virus vaccine does not induce HIV target cell activation

Motivators to Participate in aNon-HIV Experimental Study among HIV-Infected Individuals in Nairobi, Kenya: A ConsecutiveSample of an Ebola Vaccine Clinical Trial

Analysis from the NeoOBS Global Neonatal Sepsis Prospective Observational Cohort Study Across 19 Hospitals in 11 Countries; Clinical Presentation, Treatment, Mortality Outcomes and Development of the NeoSEP Sepsis Severity Score

Clinical Presentation and 28-Day Mortality in Hospitalized Neonates and Young Infants with Clinical Sepsis: The Global NeoOBS Observational Cohort

Suchergebnisse filtern